Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Mousa, Rana Fadhil
Al-Hakeim, Hussein Kadhem
Alhaideri, Amer
and
Maes, Michael
2021.
Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates.
Metabolic Brain Disease,
Vol. 36,
Issue. 1,
p.
169.
Kandilarova, Sevdalina
Stoyanov, Drozdstoy St.
Paunova, Rositsa
Todeva-Radneva, Anna
Aryutova, Katrin
and
Maes, Michael
2021.
Effective Connectivity between Major Nodes of the Limbic System, Salience and Frontoparietal Networks Differentiates Schizophrenia and Mood Disorders from Healthy Controls.
Journal of Personalized Medicine,
Vol. 11,
Issue. 11,
p.
1110.
Maes, Michael
and
Kanchanatawan, Buranee
2021.
In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life.
CNS Spectrums,
p.
1.
Maes, Michael
and
Anderson, George
2021.
False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes.
Frontiers in Psychiatry,
Vol. 12,
Issue. ,
Maes, Michael
Vojdani, Aristo
Sirivichayakul, Sunee
Barbosa, Decio S.
and
Kanchanatawan, Buranee
2021.
Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.
Molecular Neurobiology,
Vol. 58,
Issue. 7,
p.
3319.
Al-Musawi, Ali Fattah
Al-Hakeim, Hussein Kadhem
Al-Khfaji, Zahraa Abdulrazaq
Al-Haboby, Inas H.
Almulla, Abbas F.
Stoyanov, Drozdstoj St.
and
Maes, Michael
2022.
In Schizophrenia, the Effects of the IL-6/IL-23/Th17 Axis on Health-Related Quality of Life and Disabilities Are Partly Mediated by Generalized Cognitive Decline and the Symptomatome.
International Journal of Environmental Research and Public Health,
Vol. 19,
Issue. 22,
p.
15281.
Maes, Michael HJ
and
Stoyanov, Drozdstoy
2022.
False dogmas in mood disorders research: Towards a nomothetic network approach.
World Journal of Psychiatry,
Vol. 12,
Issue. 5,
p.
651.
Al-Hakeim, Hussein Kadhem
Altufaili, Mazin Fadhil
Almulla, Abbas F.
Moustafa, Shatha Rouf
and
Maes, Michael
2022.
Increased Lipid Peroxidation and Lowered Antioxidant Defenses Predict Methamphetamine Induced Psychosis.
Cells,
Vol. 11,
Issue. 22,
p.
3694.
Al-Hakeim, Hussein Kadhem
Al-Musawi, Ali Fattah
Al-Mulla, Abbas
Al-Dujaili, Arafat Hussein
Debnath, Monojit
Maes, Michael
and
Islam, Md. Rabiul
2022.
The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis.
PLOS ONE,
Vol. 17,
Issue. 10,
p.
e0275839.
Maes, Michael
2022.
Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self.
Journal of Personalized Medicine,
Vol. 12,
Issue. 3,
p.
403.
Maruta, Nataliya О.
Kushnir, Yurii
Markova, Marianna V.
Abdryakhimova, Tsira B.
and
Denysenko, Mykhailo M.
2023.
CLINICAL-PSYCHOPATHOLOGICAL ANALYSIS OF THE STRUCTURE AND EXPRESSION OF NEGATIVE AND POSITIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA.
Clinical and Preventive Medicine,
p.
59.
Kushnir, Yu. A.
2023.
POSSIBILITIES OF USING THE SANS METHOD FOR ASSESSING THE FEATURES OF NEGATIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA.
Bulletin of Problems Biology and Medicine,
Vol. 1,
Issue. 2,
p.
210.
Maes, Michael
2023.
Major neurocognitive psychosis: a novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin’s and Bleuler’s conceptions.
Acta Neuropsychiatrica,
Vol. 35,
Issue. 3,
p.
123.
Kushnir, Yu. A.
2023.
Оцінка обтяженості клінічної симптоматики у пацієнтів з негативними симптомами при шизофренії на різних етапах захворювання.
Likarska sprava,
Maes, Michael
Andrés-Rodríguez, Laura
Vojdani, Aristo
Sirivichayakul, Sunee
Barbosa, Decio S.
and
Kanchanatawan, Buranee
2023.
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like
Symptoms are Driven by Breakdown of the Paracellular Pathway with
Increased Zonulin and Immune Activation-Associated Neurotoxicity.
CNS & Neurological Disorders - Drug Targets,
Vol. 22,
Issue. 2,
p.
215.
Türk, Yaşar
Devecioğlu, İsmail
Küskün, Atakan
Öge, Cem
Beyazyüz, Elmas
and
Albayrak, Yakup
2023.
ROI-based analysis of diffusion indices in healthy subjects and subjects with deficit or non-deficit syndrome schizophrenia.
Psychiatry Research: Neuroimaging,
Vol. 336,
Issue. ,
p.
111726.
Kushnir , Yu.A.
2024.
Socio-demographic characteristics of patients with negative and positive symptoms in schizophrenia.
Medicni perspektivi,
Vol. 29,
Issue. 1,
p.
151.
Maruta, N.
and
Kushnir, Y.
2024.
Characteristics of the affective sphere in patients with negative symptoms in schizophrenia.
Lviv clinical bulletin,
Vol. 3-4,
Issue. 43-44,
p.
16.